Secondary colorectal carcinoma after childhood cancer

Journal of Clinical Oncology

Volumn 30, Issue 20, 2012, Pages 2552-2558

  Nottage, Kerri ^a   McFarlane, Joshua ^b   Krasin, Matthew J ^a   Li, Chenghong ^a   Srivastava, Deokumar ^a   Robison, Leslie L ^a   Hudson, Melissa M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; EPIPODOPHYLLOTOXIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CHILD; CHILDHOOD CANCER; CHRONIC MYELOID LEUKEMIA; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; FEMALE; FOLLOW UP; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RECTUM CARCINOMA; RETINOBLASTOMA; RHABDOMYOSARCOMA; SCHOOL CHILD; SECONDARY COLORECTAL CARCINOMA;

ADENOCARCINOMA; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SURVIVORS; YOUNG ADULT;

EID: 84864049067     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.8760     Document Type: Article

References (42)

1. Altekruse SF, Kosary CL, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD. http://seer.cancer. gov/csr/1975-2007/
2. Friedman DL, Whitton J, Leisenring W, et al: Subsequent neoplasms in 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 102:1083-1095, 2010
3. Neglia JP, Friedman DL, Yasui Y, et al: Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 93:618-629, 2001 (Pubitemid 32409629)
4. de Vathaire F, Hawkins M, Campbell S, et al: Second malignant neoplasms after a first cancer in childhood: Temporal pattern of risk according to type of treatment. Br J Cancer 79:1884-1893, 1999 (Pubitemid 29132320)
5. Hawkins MM, Draper GJ, Kingston JE: Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 56:339-347, 1987 (Pubitemid 17158825)
6. Mertens AC, Yasui Y, Neglia JP, et al: Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 19:3163-3172, 2001 (Pubitemid 32591432)
7. Möller TR, Garwicz S, Barlow L, et al: Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic countries. J Clin Oncol 19:3173-3181, 2001 (Pubitemid 32591433)
8. Reulen RC, Winter DL, Frobisher C, et al: Long-term cause-specific mortality among survivors of childhood cancer. JAMA 304:172-179, 2010
9. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003 (Pubitemid 46621816)
10. Reulen RC, Frobisher C, Winter DL, et al: Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305:2311-2319, 2011
11. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996 (Pubitemid 26089355)
12. Bassal M, Mertens AC, Taylor L, et al: Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 24:476-483, 2006 (Pubitemid 46630467)
13. Olsen JH, Garwicz S, Hertz H, et al: Second malignant neoplasms after cancer in childhood or adolescence: Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 307:1030-1036, 1993
14. Leung W, Sandlund JT, Hudson MM, et al: Second malignancy after treatment of childhood non-Hodgkin lymphoma. Cancer 92:1959-1966, 2001 (Pubitemid 32952517)
15. Pratt CB, Meyer WH, Luo X, et al: Second malignant neoplasms occurring in survivors of osteosarcoma. Cancer 80:960-965, 1997 (Pubitemid 27360479)
16. Prabakaran S, Senthilnathan SV, Venkatadesikalu M, et al: Adenocarcinoma of the colon as a second malignancy in a child. Pediatr Surg Int 17:475-477, 2001 (Pubitemid 32634653)
17. Kimball Dalton VM, Gelber RD, Li F, et al: Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol 16:2848-2853, 1998 (Pubitemid 28363051)
18. Densmore TL, Langer JC, Molleston JP, et al: Colorectal adenocarcinoma as a second malignant neoplasm following Wilms' tumor and rhabdomyosarcoma. Med Pediatr Oncol 27:556-560, 1996 (Pubitemid 26365302)
19. Scaradavou A, Heller G, Sklar CA, et al: Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer 76:1860-1867, 1995
20. Brugha RE, Sherwood W, Scarsbrook A, et al: Rectal adenocarcinoma following cranio-spinal radiotherapy for cerebellar medulloblastoma. Pediatr Surg Int 23:605-607, 2007 (Pubitemid 46800675)
21. Preston DL, Kusumi S, Tomonaga M, et al: Cancer incidence in atomic bomb survivors: Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 137:S68-S97, 1994 (Pubitemid 24060247)
22. Green DM, Hyland A, Barcos MP, et al: Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 18:1492-1499, 2000 (Pubitemid 30205395)
23. Thompson DE, Mabuchi K, Ron E, et al: Cancer incidence in atomic bomb survivors: Part II. Solid tumors, 1958-1987. Radiat Res 137:S17-S67, 1994 (Pubitemid 24060246)
24. Birdwell SH, Hancock SL, Varghese A, et al: Gastrointestinal cancer after treatment of Hodgkin's disease. Int J Radiat Oncol Biol Phys 37:67-73, 1997 (Pubitemid 27090135)
25. van Leeuwen FE, Klokman WJ, Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000 (Pubitemid 30078530)
26. Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000 (Pubitemid 30078531)
27. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data (ed 2). New York, NY, John Wiley & Sons, 1980, pp 163-188
28. Hirji KF, Mehta CR, Patel NR: Exact inference for matched case-control studies. Biometrics 44:803-814, 1988
29. Cox DR, Snell EJ: The Analysis of Binary Data: Monographs on Statistics and Applied Probability 32 (ed 2). London, United Kingdom, Chapman & Hall
30. Richardson DB: A simple approach for fitting linear relative rate models in SAS. Am J Epidemiol 168:1333-1338, 2008
31. Richardson DB, Kaufman JS: Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol 169:756-760, 2009
32. Swerdlow AJ, Douglas AJ, Hudson GV, et al: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 304:1137-1143, 1992
33. Pedersen-Bjergaard J, Specht L, Larsen SO, et al: Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease: Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 2:83-88, 1987 (Pubitemid 17090517)
34. Kaldor JM, Day NE, Clarke EA, et al: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990 (Pubitemid 20023826)
35. Pui CH, Hancock ML, Raimondi SC, et al: Myeloid neoplasia in children treated for solid tumours. Lancet 336:417-421, 1990 (Pubitemid 20252446)
36. Rowley JD, Golomb HM, Vardiman JW: Non-random chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 58:759-767, 1981 (Pubitemid 11015833)
37. Eddy DM: Screening for colorectal cancer. Ann Intern Med 113:373-384, 1990
38. Troisi RJ, Freedman AN, Devesa SS: Incidence of colorectal carcinoma in the U.S.: An update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 85:1670-1676, 1999 (Pubitemid 29169666)
39. Lynch HT, de la Chapelle A: Hereditary colorectal cancer. N Engl J Med 348:919-932, 2003 (Pubitemid 36298000)
40. Wong P, Verselis SJ, Garber JE, et al: Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 130:73-79, 2006 (Pubitemid 43049837)
41. Burt RW, Barthel JS, Dunn KB, et al: NCCN clinical practice guidelines in oncology: Colorectal cancer screening. J Natl Compr Canc Netw 8:8-61, 2010
42. Smith RA, Cokkinides V, Brooks D, et al: Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 61:8-30, 2011